{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T07:08:08Z","timestamp":1772176088233,"version":"3.50.1"},"reference-count":187,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.573583","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T04:34:33Z","timestamp":1601354073000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["In the Crosshairs: RNA Viruses OR Complement?"],"prefix":"10.3389","volume":"11","author":[{"given":"Nisha Asok","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umerali","family":"Kunnakkadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabu","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John Bernet","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00001","article-title":"Keeping it all going-complement meets metabolism.","volume":"8","author":"Kolev","year":"2017","journal-title":"Front Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system.","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2249.1997.d01-890.x","article-title":"Extrahepatic complement biosynthesis: where, when and why?","volume":"107","author":"Morgan","year":"1997","journal-title":"Clin Exp Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.15252\/embj.201591881","article-title":"Complement activation, regulation, and molecular basis for complement-related diseases.","volume":"34","author":"Bajic","year":"2015","journal-title":"EMBO J."},{"key":"B5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts.","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.addr.2011.06.005","article-title":"Complement in health and disease.","volume":"63","author":"Carroll","year":"2011","journal-title":"Adv Drug Deliv. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneph.2016.70","article-title":"Complement in disease: a defence system turning offensive.","volume":"12","author":"Ricklin","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1078\/0171-2985-00146","article-title":"The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes.","volume":"205","author":"Schwaeble","year":"2002","journal-title":"Immunobiology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1084\/jem.138.6.1305","article-title":"Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.","volume":"138","author":"Fearon","year":"1973","journal-title":"J Exp Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"34809","DOI":"10.1074\/jbc.m705646200","article-title":"Profiling the enzymatic properties and inhibition of human complement factor B.","volume":"282","author":"Le","year":"2007","journal-title":"J Biol Chem."},{"key":"B11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1126\/science.120.3112.279","article-title":"The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.","volume":"120","author":"Pillemer","year":"1954","journal-title":"Science."},{"key":"B12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.imlet.2004.11.010","article-title":"Complement: central to innate immunity and bridging to adaptive responses.","volume":"97","author":"Morgan","year":"2005","journal-title":"Immunol Lett."},{"key":"B13","first-page":"p. 327","author":"Carrol","year":"2004","journal-title":"Regulation by Complement of Acquired Immunity, The Human Complement System in Health and Disease."},{"key":"B14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins.","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2005.10.014","article-title":"Membrane complement regulatory proteins.","volume":"118","author":"Kim","year":"2006","journal-title":"Clin Immunol."},{"key":"B16","first-page":"86","article-title":"The origin and virulence of the 1918 \u201cSpanish\u201d influenza virus.","volume":"150","author":"Taubenberger","year":"2006","journal-title":"Proc Am Philos Soc."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1099\/0022-1317-68-4-1135","article-title":"Inactivation of influenza B virus by normal guinea-pig serum.","author":"Yamamoto","year":"1987","journal-title":"J Gen Virol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1128\/jvi.02128-06","article-title":"Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity.","volume":"81","author":"Jayasekera","year":"2007","journal-title":"J Virol."},{"key":"B19","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.4049\/jimmunol.130.3.1317","article-title":"Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.","volume":"130","author":"Beebe","year":"1983","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1006\/bbrc.1995.2886","article-title":"A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells.","volume":"217","author":"Reading","year":"1995","journal-title":"Biochem Biophys Res Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1046\/j.1365-2567.1999.00781.x","article-title":"Human mannan-binding lectin inhibits the infection of influenza A virus without complement.","volume":"97","author":"Kase","year":"1999","journal-title":"Immunology."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006248","article-title":"Synergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.","volume":"13","author":"Rattan","year":"2017","journal-title":"PLoS Pathog."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5940","DOI":"10.1128\/jvi.00193-11","article-title":"Interactions of human complement with virus particles containing the Nipah virus glycoproteins.","volume":"85","author":"Johnson","year":"2011","journal-title":"J Virol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/s0042-6822(88)90105-5","article-title":"Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization.","volume":"167","author":"Vasantha","year":"1988","journal-title":"Virology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1099\/vir.0.79880-0","article-title":"Cell surface activation of the alternative complement pathway by the fusion protein of measles virus.","volume":"85","author":"Devaux","year":"2004","journal-title":"J Gen Virol."},{"key":"B26","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.4049\/jimmunol.123.5.2144","article-title":"Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab\u2019)2 and Fab\u2019 fragments.","volume":"123","author":"Sissons","year":"1979","journal-title":"J Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.virol.2008.03.022","article-title":"Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus.","volume":"376","author":"Johnson","year":"2008","journal-title":"Virology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/bf01315298","article-title":"Activation of the alternative complement pathway by mumps infected cells: relationship to viral neuraminidase activity.","volume":"87","author":"Hirsch","year":"1986","journal-title":"Arch Virol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"9250","DOI":"10.1128\/jvi.01111-13","article-title":"Point mutations in the paramyxovirus F protein that enhance fusion activity shift the mechanism of complement-mediated virus neutralization.","volume":"87","author":"Johnson","year":"2013","journal-title":"J Virol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"12708","DOI":"10.1128\/jvi.00886-12","article-title":"Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion.","volume":"86","author":"Biswas","year":"2012","journal-title":"J Virol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4049\/jimmunol.118.1.348","article-title":"Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement.","volume":"118","author":"Welsh","year":"1977","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1073\/pnas.77.1.559","article-title":"Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.","volume":"77","author":"Sissons","year":"1980","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jmv.1890090210","article-title":"Appearance of complement components and immunoglobulins on nasopharyngeal epithelial cells following naturally acquired infection with respiratory syncytial virus.","volume":"9","author":"Kaul","year":"1982","journal-title":"J Med Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"10880","DOI":"10.1128\/jvi.01162-12","article-title":"The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complement.","volume":"86","author":"Bukreyev","year":"2012","journal-title":"J Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0264-410x(95)00222-m","article-title":"Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2.","volume":"14","author":"Corbeil","year":"1996","journal-title":"Vaccine."},{"key":"B36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/bf01310889","article-title":"Complement activation by respiratory syncytial virus-infected cells.","volume":"88","author":"Edwards","year":"1986","journal-title":"Arch Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/jmv.20046","article-title":"Role of complement in neutralization of respiratory syncytial virus.","volume":"72","author":"Yoder","year":"2004","journal-title":"J Med Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s13238-010-0088-9","article-title":"Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry.","volume":"1","author":"Brown","year":"2010","journal-title":"Protein Cell."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1086\/500949","article-title":"Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement.","volume":"193","author":"Avirutnan","year":"2006","journal-title":"J Infect Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1086\/343813","article-title":"High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.","volume":"186","author":"Libraty","year":"2002","journal-title":"J Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jmv.10261","article-title":"Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.","volume":"69","author":"Lin","year":"2003","journal-title":"J Med Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1128\/jvi.00992-07","article-title":"Infection-enhancing and -neutralizing activities of mouse monoclonal antibodies against dengue type 2 and 4 viruses are controlled by complement levels.","volume":"82","author":"Yamanaka","year":"2008","journal-title":"J Virol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.chom.2007.09.015","article-title":"Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner.","volume":"2","author":"Mehlhop","year":"2007","journal-title":"Cell Host Microbe."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1128\/jvi.01850-08","article-title":"Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells.","volume":"83","author":"Krishna","year":"2009","journal-title":"J Virol."},{"key":"B45","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1128\/JVI.79.12.7466-7477.2005","article-title":"Complement activation is required for induction of a protective antibody response against West Nile virus infection.","volume":"79","author":"Mehlhop","year":"2005","journal-title":"J Virol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.chom.2010.07.007","article-title":"Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin.","volume":"8","author":"Fuchs","year":"2010","journal-title":"Cell Host Microbe."},{"key":"B47","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.virusres.2013.11.007","article-title":"C1q binding to dengue virus decreases levels of infection and inflammatory molecules transcription in THP-1 cells.","volume":"179","author":"Douradinha","year":"2014","journal-title":"Virus Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.chom.2009.09.003","article-title":"Complement protein C1q reduces the stoichiometric threshold for antibody-mediated neutralization of West Nile virus.","volume":"6","author":"Mehlhop","year":"2009","journal-title":"Cell Host Microbe."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000060","article-title":"Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.","volume":"4","author":"Nelson","year":"2008","journal-title":"PLoS Pathog."},{"key":"B50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.virol.2011.01.003","article-title":"The lectin pathway of complement activation contributes to protection from West Nile virus infection.","volume":"412","author":"Fuchs","year":"2011","journal-title":"Virology."},{"key":"B51","doi-asserted-by":"crossref","first-page":"e00276","DOI":"10.1128\/mBio.00276-11","article-title":"Complement-mediated neutralization of dengue virus requires mannose-binding lectin.","volume":"2","author":"Avirutnan","year":"2011","journal-title":"mBio."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1084\/jem.20052388","article-title":"Protective immune responses against West Nile virus are primed by distinct complement activation pathways.","volume":"203","author":"Mehlhop","year":"2006","journal-title":"J Exp Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virol.2009.08.019","article-title":"Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism.","volume":"393","author":"Mehlhop","year":"2009","journal-title":"Virology."},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02177","article-title":"Active human complement reduces the Zika virus load via formation of the membrane-attack complex.","volume":"9","author":"Schiela","year":"2018","journal-title":"Front Immunol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.4049\/jimmunol.127.5.1740","article-title":"Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance.","volume":"127","author":"Hirsch","year":"1981","journal-title":"J Immunol."},{"key":"B56","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/iai.30.3.899-901.1980","article-title":"Role of complement in viral infections: participation of terminal complement components (C5 to C9) in recovery of mice from Sindbis virus infection.","volume":"30","author":"Hirsch","year":"1980","journal-title":"Infect Immunity."},{"key":"B57","doi-asserted-by":"crossref","first-page":"e2062","DOI":"10.1128\/JVI.02062-19","article-title":"A Factor I-Like activity associated with chikungunya virus contributes to its resistance to the human complement system.","volume":"94","author":"Nag","year":"2020","journal-title":"J Virol."},{"key":"B58","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.4049\/jimmunol.123.6.2518","article-title":"Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.","volume":"123","author":"Mills","year":"1979","journal-title":"J Immunol."},{"key":"B59","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.4049\/jimmunol.126.4.1562","article-title":"Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.","volume":"126","author":"Beebe","year":"1981","journal-title":"J Immunol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"9929","DOI":"10.1128\/jvi.01154-12","article-title":"Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and vesicular stomatitis virus to neutralization.","volume":"86","author":"Johnson","year":"2012","journal-title":"J Virol."},{"key":"B61","doi-asserted-by":"crossref","first-page":"e994","DOI":"10.1128\/JVI.00994-19","article-title":"Complement-mediated neutralization of a potent neurotropic human pathogen, chandipura virus, is dependent on C1q.","volume":"93","author":"Kunnakkadan","year":"2019","journal-title":"J Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1099\/vir.0.81199-0","article-title":"Mannose-binding lectin binds to Ebola and Marburg envelope glycoproteins, resulting in blocking of virus interaction with DC-SIGN and complement-mediated virus neutralization.","volume":"86","author":"Ji","year":"2005","journal-title":"J Gen Virol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1084\/jem.174.6.1417","article-title":"Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.","volume":"174","author":"Ebenbichler","year":"1991","journal-title":"J Exp Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/00002030-199310000-00002","article-title":"Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins.","volume":"7","author":"Haurum","year":"1993","journal-title":"Aids."},{"key":"B65","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.molimm.2004.06.015","article-title":"Mannose binding lectin (MBL) and HIV.","volume":"42","author":"Ji","year":"2005","journal-title":"Mol Immunol."},{"key":"B66","first-page":"377","article-title":"Human immunodeficiency virus (HIV)-infected cells and free virus directly activate the classical complement pathway in rabbit, mouse and guinea-pig sera; activation results in virus neutralization by virolysis.","volume":"73","author":"Spear","year":"1991","journal-title":"Immunology."},{"key":"B67","first-page":"184","article-title":"Interaction of complement and specific antibodies with the external glycoprotein 120 of HIV-1.","volume":"85","author":"Prohaszka","year":"1995","journal-title":"Immunology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1182\/blood.v87.6.2329.bloodjournal8762329","article-title":"Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120.","volume":"87","author":"Susal","year":"1996","journal-title":"Blood."},{"key":"B69","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.4049\/jimmunol.152.12.6028","article-title":"Complement activation by recombinant HIV-1 glycoprotein gp120.","volume":"152","author":"Susal","year":"1994","journal-title":"J Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1034\/j.1600-065x.2001.1800115.x","article-title":"The supportive role of complement in HIV pathogenesis.","volume":"180","author":"Stoiber","year":"2001","journal-title":"Immunol Rev."},{"key":"B71","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.4049\/jimmunol.161.10.5712","article-title":"Human complement component C1q inhibits the infectivity of cell-free HTLV-I.","volume":"161","author":"Ikeda","year":"1998","journal-title":"J Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1128\/jvi.02427-14","article-title":"A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b.","volume":"89","author":"Johnson","year":"2015","journal-title":"J Virol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1099\/0022-1317-66-1-121","article-title":"Interaction of Ross River virus with the complement system.","author":"Aaskov","year":"1985","journal-title":"J Gen Virol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1128\/jvi.02799-06","article-title":"Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease.","volume":"81","author":"Morrison","year":"2007","journal-title":"J Virol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.virol.2017.12.022","article-title":"Ross River virus envelope glycans contribute to disease through activation of the host complement system.","volume":"515","author":"Gunn","year":"2018","journal-title":"Virology."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002586","article-title":"Mannose binding lectin is required for alphavirus-induced arthritis\/myositis.","volume":"8","author":"Gunn","year":"2012","journal-title":"PLoS Pathog."},{"key":"B77","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/429631","article-title":"Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection.","volume":"191","author":"Ip","year":"2005","journal-title":"J Infect Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"8753","DOI":"10.1128\/jvi.00554-10","article-title":"A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.","volume":"84","author":"Zhou","year":"2010","journal-title":"J Virol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1373\/clinchem.2005.061689","article-title":"Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome.","volume":"52","author":"Pang","year":"2006","journal-title":"Clin Chem."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.29.20041962","article-title":"Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation.","author":"Gao","year":"","journal-title":"MedRxiv."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases.","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact.","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int."},{"key":"B83","doi-asserted-by":"publisher","first-page":"11263","DOI":"10.1128\/jvi.01352-08","article-title":"Complement receptor 3 promotes severe ross river virus-induced disease.","volume":"82","author":"Morrison","year":"2008","journal-title":"J Virol."},{"key":"B84","first-page":"316","article-title":"Complement and dengue haemorrhagic fever\/shock syndrome.","volume":"18","author":"Malasit","year":"1987","journal-title":"Southeast Asian J Trop Med Public Health."},{"key":"B85","first-page":"102","article-title":"The role of complement in hemorrhagic shock syndrome (dengue).","volume":"86","author":"Bokisch","year":"1973","journal-title":"Trans Assoc Am Phys."},{"key":"B86","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1056\/nejm197311082891902","article-title":"The potential pathogenic role of complement in dengue hemorrhagic shock syndrome.","volume":"289","author":"Bokisch","year":"1973","journal-title":"N Engl J Med."},{"key":"B87","first-page":"385","article-title":"Serum complement level in dengue hemorrhagic fever.","author":"Nishioka","year":"1974","journal-title":"Allergie Immunol."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006782","article-title":"Alternative complement pathway deregulation is correlated with dengue severity.","volume":"4","author":"Nascimento","year":"2009","journal-title":"PLoS One."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004086","article-title":"Deficient IFN signaling by myeloid cells leads to MAVS-dependent virus-induced sepsis.","volume":"10","author":"Pinto","year":"2014","journal-title":"PLoS Pathog."},{"key":"B90","doi-asserted-by":"publisher","first-page":"569","DOI":"10.4269\/ajtmh.1983.32.569","article-title":"Crossed immunoelectrophoresis for the detection of split products of the third complement in dengue hemorrhagic fever. I. Observations in patients\u2019 plasma.","volume":"32","author":"Churdboonchart","year":"1983","journal-title":"Am J Trop Med Hygiene."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.4269\/ajtmh.1984.33.1239","article-title":"Crossed immunoelectrophoresis for the detection of split products of the third complement component in dengue hemorrhagic fever. II. In vitro activation by dengue viral antigen.","volume":"33","author":"Churdboonchart","year":"1984","journal-title":"Am J Trop Med Hygiene."},{"key":"B92","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/0035-9203(92)90186-g","article-title":"Complement pathway activity in serum from patients with classical dengue fever.","volume":"86","author":"Shaio","year":"1992","journal-title":"Trans R Soc Trop Med Hygiene."},{"key":"B93","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.4049\/jimmunol.161.11.6338","article-title":"Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis.","volume":"161","author":"Avirutnan","year":"1998","journal-title":"J Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/587699","article-title":"Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever.","volume":"197","author":"Ubol","year":"2008","journal-title":"J Infect Dis."},{"key":"B95","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1084\/jem.158.1.258","article-title":"Complement receptor mediates enhanced flavivirus replication in macrophages.","volume":"158","author":"Cardosa","year":"1983","journal-title":"J Exp Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature18283","article-title":"A complement-microglial axis drives synapse loss during virus-induced memory impairment.","volume":"534","author":"Vasek","year":"2016","journal-title":"Nature."},{"key":"B97","doi-asserted-by":"publisher","first-page":"7089","DOI":"10.1073\/pnas.83.18.7089","article-title":"Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients.","volume":"83","author":"Wiley","year":"1986","journal-title":"Proc Natl Acad Sci USA."},{"key":"B98","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0794-9","article-title":"HIV induces expression of complement component C3 in astrocytes by NF-kappaB-dependent activation of interleukin-6 synthesis.","volume":"14","author":"Nitkiewicz","year":"2017","journal-title":"J Neuroinflamm."},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046178","article-title":"National Neuro, The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.","volume":"7","author":"Gelman","year":"2012","journal-title":"PLoS One."},{"key":"B100","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1128\/jvi.75.6.2604-2516.2001","article-title":"Human immunodeficiency virus type 1 induces expression of complement factors in human astrocytes.","volume":"75","author":"Speth","year":"2001","journal-title":"J Virol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1034\/j.1600-0404.2000.101002116.x","article-title":"Cerebrospinal fluid C3 and C4 indexes in immunological disorders of the central nervous system.","volume":"101","author":"Jongen","year":"2000","journal-title":"Acta Neurol Scand."},{"key":"B102","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jneuroim.2004.02.013","article-title":"Complement synthesis and activation in the brain of SIV-infected monkeys.","volume":"151","author":"Speth","year":"2004","journal-title":"J Neuroimmunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00002030-199204000-00004","article-title":"Decreased expression of the membrane inhibitor of complement-mediated cytolysis CD59 on T-lymphocytes of HIV-infected patients.","volume":"6","author":"Weiss","year":"1992","journal-title":"Aids."},{"key":"B104","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/13550280009006382","article-title":"Expression of complement inhibitor protein CD59 in human neuronal and glial cell lines treated with HIV-1 gp41 peptides.","volume":"6","author":"Chong","year":"2000","journal-title":"J Neurovirol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.virol.2010.12.045","article-title":"Complement and viral pathogenesis.","volume":"411","author":"Stoermer","year":"2011","journal-title":"Virology."},{"key":"B106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01001","article-title":"The complement system and C1q in chronic hepatitis C virus infection and mixed cryoglobulinemia.","volume":"9","author":"El-Shamy","year":"2018","journal-title":"Front immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/08820139.2014.932378","article-title":"Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.","volume":"44","author":"Fadda","year":"2015","journal-title":"Immunol Invest."},{"key":"B108","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1365-2249.2006.03153.x","article-title":"Anti-C1q antibodies in hepatitis C virus infection.","volume":"145","author":"Saadoun","year":"2006","journal-title":"Clin Exp Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1164\/rccm.202005-1926ed","article-title":"Complement activation during critical illness: current findings and an outlook in the Era of COVID-19.","volume":"202","author":"Bosmann","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.4049\/jimmunol.173.4.2524","article-title":"Complement C5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses.","volume":"173","author":"Kim","year":"2004","journal-title":"J Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jinf.2014.05.006","article-title":"Dynamic behavior of lymphocyte subgroups correlates with clinical outcomes in human H7N9 infection.","volume":"69","author":"Chen","year":"2014","journal-title":"J Infect."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092823","article-title":"Severe H7N9 infection is associated with decreased antigen-presenting capacity of CD14+ cells.","volume":"9","author":"Diao","year":"2014","journal-title":"PLoS One."},{"key":"B113","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in inflammatory responses.","volume":"23","author":"Guo","year":"2005","journal-title":"Annu Rev Immunol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2147\/copd.s51226","article-title":"Oxidative stress and free radicals in COPD\u2013implications and relevance for treatment.","volume":"9","author":"Domej","year":"2014","journal-title":"Int J Chronic Obstructive Pulm. Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1172\/jci114499","article-title":"Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice.","volume":"85","author":"Akaike","year":"1990","journal-title":"J Clin Invest."},{"key":"B116","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.intimp.2018.03.029","article-title":"C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury.","volume":"59","author":"Song","year":"2018","journal-title":"Int Immunopharm."},{"key":"B117","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/infdis\/jir691","article-title":"Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection.","volume":"205","author":"Ling","year":"2012","journal-title":"J Infect Dis."},{"key":"B118","article-title":"Assemble and interact: pleiotropic functions of the HCV core protein.","author":"Polyak","year":"2006","journal-title":"Hepatitis C Viruses: Genomes and Molecular Biology."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1189\/jlb.0507268","article-title":"HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production.","volume":"82","author":"Waggoner","year":"2007","journal-title":"J Leukoc Biol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.clim.2009.05.002","article-title":"Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.","volume":"132","author":"Cummings","year":"2009","journal-title":"Clin Immunol."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000975","article-title":"HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3\/H2O2 pathway.","volume":"6","author":"Fausther-Bovendo","year":"2010","journal-title":"PLoS Pathog."},{"key":"B122","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/infdis\/170.2.429","article-title":"Binding of human immunodeficiency virus type 1 to the C3b\/C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. National Institutes of Health AIDS Vaccine Clinical Trials Networks.","volume":"170","author":"Montefiori","year":"1994","journal-title":"J Infect Dis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1128\/jvi.74.1.552-555.2000","article-title":"Immune complexes containing human immunodeficiency virus type 1 primary isolates bind to lymphoid tissue B lymphocytes and are infectious for T lymphocytes.","volume":"74","author":"Jakubik","year":"2000","journal-title":"J Virol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1084\/jem.192.5.637","article-title":"B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells.","volume":"192","author":"Moir","year":"2000","journal-title":"J Exp Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"4775","DOI":"10.4049\/jimmunol.173.8.4775","article-title":"Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b\/CD18).","volume":"173","author":"Bajtay","year":"2004","journal-title":"J Immunol."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000891","article-title":"Complement as an endogenous adjuvant for dendritic cell-mediated induction of retrovirus-specific CTLs.","volume":"6","author":"Banki","year":"2010","journal-title":"PLoS Pathog."},{"key":"B127","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1128\/jvi.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.","volume":"68","author":"Borrow","year":"1994","journal-title":"J Virol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1128\/jvi.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.4049\/jimmunol.166.5.3410","article-title":"C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection.","volume":"166","author":"Kacani","year":"2001","journal-title":"J Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1002\/eji.200636820","article-title":"HIV-1 induced generation of C5a attracts immature dendriticcells and promotes infection of autologous T cells.","volume":"37","author":"Soederholm","year":"2007","journal-title":"Eur J Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1089\/aid.2015.0099","article-title":"A novel role for the receptor of the complement cleavage fragment C5a, C5aR1, in CCR5-mediated entry of HIV into macrophages.","volume":"32","author":"Moreno-Fernandez","year":"2016","journal-title":"AIDS Res Human Retroviruses."},{"key":"B132","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/infdis\/jiv014","article-title":"Immediate T-helper 17 polarization upon triggering CD11b\/c on HIV-exposed dendritic cells.","volume":"212","author":"Wilflingseder","year":"2015","journal-title":"J Infect Dis."},{"key":"B133","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaci.2012.08.025","article-title":"Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes.","volume":"130","author":"Posch","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005005","article-title":"Complement-opsonized HIV-1 overcomes restriction in dendritic cells.","volume":"11","author":"Posch","year":"2015","journal-title":"PLoS Pathog."},{"key":"B135","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1165\/rcmb.2012-0428oc","article-title":"Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection.","volume":"49","author":"Sun","year":"2013","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1111\/jth.14981","article-title":"COVID-19: a collision of complement, coagulation and inflammatory pathways.","volume":"18","author":"Chauhan","year":"2020","journal-title":"J Thromb Haemostasis."},{"key":"B137","doi-asserted-by":"crossref","DOI":"10.1038\/emi.2015.28","article-title":"The role of C5a in acute lung injury induced by highly pathogenic viral infections.","volume":"4","author":"Wang","year":"2015","journal-title":"Emerging Microbes Infect."},{"key":"B138","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1128\/jvi.01847-07","article-title":"Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway.","volume":"82","author":"Bonaparte","year":"2008","journal-title":"J Virol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.molimm.2009.10.006","article-title":"Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.","volume":"47","author":"Hair","year":"2010","journal-title":"Mol Immunol."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082094","article-title":"Hepatitis C virus NS3\/4A protease inhibits complement activation by cleaving complement component 4.","volume":"8","author":"Mawatari","year":"2013","journal-title":"PLoS One"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1007\/s00705-016-2835-6","article-title":"Bovine viral diarrhea virus structural protein E2 as a complement regulatory protein.","volume":"161","author":"Ostachuk","year":"2016","journal-title":"Arch Virol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.4049\/jimmunol.1600323","article-title":"Secreted NS1 protects dengue virus from mannose-binding lectin-mediated neutralization.","volume":"197","author":"Thiemmeca","year":"2016","journal-title":"J Immunol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20092545","article-title":"Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.","volume":"207","author":"Avirutnan","year":"2010","journal-title":"J Exp Med."},{"key":"B144","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1099\/vir.0.014316-0","article-title":"Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA.","volume":"90","author":"Zhang","year":"2009","journal-title":"J Gen Virol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/08828240152716547","article-title":"Hepatitis C virus: immunosuppression by complement regulatory pathway.","volume":"14","author":"Yao","year":"2001","journal-title":"Viral Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2009.03.035","article-title":"Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells.","volume":"389","author":"O\u2019Beirne","year":"2009","journal-title":"Virology."},{"key":"B147","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.4049\/jimmunol.1002006","article-title":"Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes\/macrophages in hepatitis C virus infection.","volume":"186","author":"Zhang","year":"2011","journal-title":"J Immunol."},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060838","article-title":"Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors.","volume":"8","author":"Brudner","year":"2013","journal-title":"PLoS One."},{"key":"B149","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1128\/jvi.00232-16","article-title":"Enhancement of ebola virus infection via Ficolin-1 interaction with the mucin domain of GP glycoprotein.","volume":"90","author":"Favier","year":"2016","journal-title":"J Virol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1128\/jvi.06577-11","article-title":"Hepatitis C virus proteins inhibit C3 complement production.","volume":"86","author":"Mazumdar","year":"2012","journal-title":"J Virol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1128\/jvi.02449-10","article-title":"Transcriptional repression of C4 complement by hepatitis C virus proteins.","volume":"85","author":"Banerjee","year":"2011","journal-title":"J Virol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1128\/jvi.00174-13","article-title":"Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function.","volume":"87","author":"Kim","year":"2013","journal-title":"J Virol."},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101422","article-title":"Inhibition of c3 convertase activity by hepatitis C virus as an additional lesion in the regulation of complement components.","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One."},{"key":"B154","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1128\/jvi.02988-13","article-title":"Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis.","volume":"88","author":"Kim","year":"2014","journal-title":"J Virol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.virol.2016.07.030","article-title":"Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization.","volume":"497","author":"Li","year":"2016","journal-title":"Virology."},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/v10050219","article-title":"Relative contribution of cellular complement inhibitors CD59, CD46, and CD55 to parainfluenza Virus 5 inhibition of complement-mediated neutralization.","volume":"10","author":"Li","year":"2018","journal-title":"Viruses."},{"key":"B157","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/eji.1830250147","article-title":"Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement.","volume":"25","author":"Marschang","year":"1995","journal-title":"Eur J Immunol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1099\/0022-1317-78-8-1907","article-title":"Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.","author":"Saifuddin","year":"1997","journal-title":"J Gen Virol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.1128\/jvi.00713-09","article-title":"The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.","volume":"83","author":"Johnson","year":"2009","journal-title":"J Virol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/hep.24686","article-title":"CD59 incorporation protects hepatitis C virus against complement-mediated destruction.","volume":"55","author":"Amet","year":"2012","journal-title":"Hepatology."},{"key":"B161","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1006\/viro.1994.1622","article-title":"Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.","volume":"205","author":"Montefiori","year":"1994","journal-title":"Virology."},{"key":"B162","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1084\/jem.182.2.501","article-title":"Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1.","volume":"182","author":"Saifuddin","year":"1995","journal-title":"J Exp Med."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1172\/jci118190","article-title":"Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.","volume":"96","author":"Schmitz","year":"1995","journal-title":"J Clin Invest."},{"key":"B164","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.4049\/jimmunol.155.9.4376","article-title":"Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia\/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV).","volume":"155","author":"Spear","year":"1995","journal-title":"J Immunol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"7902","DOI":"10.1128\/jvi.00917-13","article-title":"Hepatitis C virus infection upregulates CD55 expression on the hepatocyte surface and promotes association with virus particles.","volume":"87","author":"Mazumdar","year":"2013","journal-title":"J Virol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.4049\/jimmunol.1600631","article-title":"Distinct CD55 isoform synthesis and inhibition of complement-dependent cytolysis by Hepatitis C virus.","volume":"197","author":"Kwon","year":"2016","journal-title":"J Immunol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4049\/jimmunol.1100750","article-title":"Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation.","volume":"187","author":"Avirutnan","year":"2011","journal-title":"J Immunol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"19111","DOI":"10.1073\/pnas.0605668103","article-title":"West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H.","volume":"103","author":"Chung","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.bbrc.2007.08.137","article-title":"Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1.","volume":"362","author":"Kurosu","year":"2007","journal-title":"Biochem Biophys Res Commun."},{"key":"B170","doi-asserted-by":"publisher","first-page":"9570","DOI":"10.1128\/jvi.00912-16","article-title":"Inhibition of the membrane attack complex by dengue virus NS1 through interaction with vitronectin and terminal complement proteins.","volume":"90","author":"Conde","year":"2016","journal-title":"J Virol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1089\/aid.1995.11.577","article-title":"Direct interaction of complement factor H with the C1 domain of HIV type 1 glycoprotein 120.","volume":"11","author":"Pinter","year":"1995","journal-title":"AIDS Res Human Retroviruses."},{"key":"B172","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1089\/aid.1995.11.971","article-title":"HIV glycoprotein 41 and complement factor H interact with each other and share functional as well as antigenic homology.","volume":"11","author":"Pinter","year":"1995","journal-title":"AIDS Res Human Retroviruses."},{"key":"B173","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1084\/jem.183.1.307","article-title":"Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55).","volume":"183","author":"Stoiber","year":"1996","journal-title":"J Exp Med."},{"key":"B174","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1073\/pnas.91.13.6245","article-title":"Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.","volume":"91","author":"Bergelson","year":"1994","journal-title":"Proc Natl Acad Sci USA."},{"key":"B175","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1074\/jbc.M212561200","article-title":"Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A.","volume":"278","author":"Williams","year":"2003","journal-title":"J Biol Chem."},{"key":"B176","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1128\/JVI.69.6.3873-3877.1995","article-title":"Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment.","volume":"69","author":"Shafren","year":"1995","journal-title":"J Virol."},{"key":"B177","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1128\/JVI.71.6.4736-4743.1997","article-title":"Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.","volume":"71","author":"Shafren","year":"1997","journal-title":"J Virol."},{"key":"B178","doi-asserted-by":"crossref","first-page":"9380","DOI":"10.1128\/JVI.72.11.9380-9383.1998","article-title":"Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.","volume":"72","author":"Karnauchow","year":"1998","journal-title":"J Virol."},{"key":"B179","doi-asserted-by":"crossref","first-page":"5143","DOI":"10.1128\/JVI.70.8.5143-5152.1996","article-title":"The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).","volume":"70","author":"Karnauchow","year":"1996","journal-title":"J Virol."},{"key":"B180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cell.2005.10.035","article-title":"Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions.","volume":"124","author":"Coyne","year":"2006","journal-title":"Cell."},{"key":"B181","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain).","volume":"75","author":"Dorig","year":"1993","journal-title":"Cell."},{"key":"B182","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1128\/JVI.67.10.6025-6032.1993","article-title":"Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus.","volume":"67","author":"Naniche","year":"1993","journal-title":"J Virol."},{"key":"B183","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/viro.1997.8581","article-title":"Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2.","volume":"233","author":"Manchester","year":"1997","journal-title":"Virology."},{"key":"B184","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1073\/pnas.91.6.2161","article-title":"Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus.","volume":"91","author":"Manchester","year":"1994","journal-title":"Proc Natl Acad Sci USA."},{"key":"B185","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/JVI.69.6.3341-3349.1995","article-title":"Functional and structural interactions between measles virus hemagglutinin and CD46.","volume":"69","author":"Nussbaum","year":"1995","journal-title":"J Virol."},{"key":"B186","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.20131092","article-title":"beta2 integrin mediates hantavirus-induced release of neutrophil extracellular traps.","volume":"211","author":"Raftery","year":"2014","journal-title":"J Exp Med."},{"key":"B187","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1073\/pnas.94.10.5389","article-title":"Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells.","volume":"94","author":"Coulson","year":"1997","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.573583\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T14:45:35Z","timestamp":1696776335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.573583\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":187,"alternative-id":["10.3389\/fimmu.2020.573583"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.573583","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"article-number":"573583"}}